A randomised phase III trial of adjuvant radio-chemotherapy comparing Irinotecan, 5FU and Leucovorin to 5FU and Leucovorin in patients with rectal cancer: A Hellenic Cooperative Oncology Group Study

European Journal of Cancer

Volumn 44, Issue 12, 2008, Pages 1693-1700

  Kalofonos, H P ^a   Bamias, A ^b   Koutras, A ^a   Papakostas, P ^c   Basdanis, G ^d   Samantas, E ^e   Karina, M ^d   Misailidou, D ^f   Pisanidis, N ^d   Pentheroudakis, G ^g   Economopoulos, T ^h   Papadimitriou, C ^b   Skarlos, D V ⁱ   Pectasides, D ^h   Stavropoulos, M ^a   Bafaloukos, D ^j   Kardamakis, D ^a   Karanikiotis, C ^k   Vourli, G ^l   Fountzilas, G ^d,f  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b ALEXANDRA HOSPITAL   (Greece)

^c HIPPOKRATION HOSPITAL   (Greece)

^d ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^e AGII ANARGIRI CANCER HOSPITAL   (Greece)

^f PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

^g UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^h NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

ⁱ HENRY DUNANT HOSPITAL   (Greece)

^j METROPOLITAN HOSPITAL   (Greece)

^k 424 General Army Hospital   (Greece)

^l Hellenic Cooperative Oncology Group   (Greece)

more..

Author keywords

5 Fluorouracil; Chemoradiotherapy; Irinotecan; Rectal cancer

Indexed keywords

ANTIEMETIC AGENT; BEVACIZUMAB; CAPECITABINE; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; LOPERAMIDE; OXALIPLATIN;

ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE FREE SURVIVAL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; GASTROINTESTINAL DISEASE; HAND FOOT SYNDROME; HEMATOLOGIC DISEASE; HUMAN; INFECTION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECTUM CANCER; RECTUM CARCINOMA; THROMBOCYTOPENIA; VOMITING;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 48349113596     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.05.025     Document Type: Article

References (26)

1. Gastrointestinal Tumor Study Group: Prolongation of the disease-free interval on surgically treated rectal carcinoma. New Engl J Med 1985;312:1465-72.
2. Krook J.E., Moertel C.G., Gunderson L.L., et al. Effective surgical adjuvant therapy for high-risk rectal cancer. New Engl J Med 324 (1991) 709-715
3. NIH Consensus Conference: Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264:1444-50.
4. Sauer R., Becker H., Hohenberg W., et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. New Engl J Med 351 (2004) 1731-1740
5. Douillard J.Y., Cunningham D., Roth A.D., et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first line treatment for metastatic colorectal carcinoma: a multicenter randomised trial. Lancet 255 (2000) 1041-1047
6. Saltz L.B., Cox J.V., Blanke C., et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. New Engl J Med 343 (2000) 905-914
7. Chau I., and Cunnigham D. Adjuvant therapy in colon cancer - what, when and how?. Ann Oncol 17 (2006) 1347-1359
8. Mehta V.K., Cho C., Ford J.M., et al. Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound - staged T3 rectal cancer. Int J Radiat Oncol Biol Phys 55 (2003) 132-137
9. Klautke G., Küchenmeister V., Foitzik T., et al. Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer: results from a phase I/II study. Br J Cancer 94 (2006) 976-981
10. Mohiuddin M., Winter K., Mitchell E., et al. Randomized phase II study of neoadjuvant combined - modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012. J Clin Oncol 24 (2006) 650-655
11. Kalofonos H.P., Kardamakis D., Bamias A., et al. Adjuvant chemotherapy using CPT-11, leucovorin plus bolus 5-fluorouracil and radiotherapy in patients with rectal cancer. A feasibility study. Anticancer Res 23 (2003) 1687-1692
12. Kalofonos H.P., Skarlos D., Bafaloukos D., et al. A phase II study with CPT-11 plus leucovorin and bolus 5fluorouracil in patients with advanced colorectal carcinoma. Cancer Invest 21 (2003) 855-862
13. Kalofonos H.P., Aravantinos G., Kosmidis P., et al. Irinotecan or oxaliplatin combined with leucovorin and 5-fuorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomised, phase II study. Ann Oncol 16 6 (2005) 869-877
14. Sargent D.J., Wieand H.S., Haller D.G., et al. Dosease free survival versus overall as a primary endpoint for adjuvant colon cancer studies: Individual patient data from 20.898 patients on 18 randomised trials. J Clin Oncol 23 (2005) 8664-8670
15. Fuchs C., Mitchell E.P., and Hoff P.M. Irinotecan in the treatment of colorectal cancer. Cancer Treat Rev 32 (2006) 491-503
16. Voelter V., Zouhair A., Vuilleumier H., et al. CPT-11 and concomitant hyperfractionated accelerated radiotherapy induce efficient local control in rectal cancer patients: results from a phase II. Br J Cancer 18 (2006) 710-716
17. Van Cutsem E, Labianca R, Hossfeld D, et al. Randomized phase III trial comparing infused irinotecan/5-fluorouracil (5-FU)/folinic acid (FA) versus 5FU/FA in stage III colon cancer patients (PETACC 3). In: ASCO, Annual Meeting Proceedings, vol. 23; 2005. p. LBA8.
18. Ychou M, Raoul JL, Douillard JY, et al. A phase III randomized trial of LV5FU2 + CPT-11 vs LV5FU2 alone in adjuvant high risk colon cancer (FNCLCC Accord 02/FFCD9802). In: ASCO, Annual Meeting Proceedings, vol. 23; 2005. p. 3502.
19. Saltz L.B., Niedzwiecki D., Hollis D., et al. Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803. J Clin Oncol 25 (2007) 3456-3461
20. Mitchell E.P. Irinotecan in preoperative combined modality therapy for locally advanced rectal cancer. Oncology 14 Suppl. 14 (2000) 56-59
21. Ruthenberg M.L., Meropol N.J., Poplin E.A., et al. Mortality associated with irinotecan plus bolus fluorouracil / leucovorin: Summary Findings of an Independent Panel. J Clin Oncol 19 (2001) 3801-3807
22. Twelves C., Wong A., Nowacki M.P., et al. Capecitabine as adjuvant treatment for stage III colon cancer. New Engl J Med 352 (2005) 2696-2704
23. Dunst J., Reese T., Sutter T., et al. Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal adenocarcinoma. J Clin Oncol 20 (2002) 1005-1009
24. Hofheinz R., von Gestertiberg-Helldorf B., Wenz F., et al. Phase I trial of capecitabine and weekly irinotecan in combination with radiotherapy for neoadjuvant therapy of rectal cancer. J Clin Oncol 23 (2005) 1350-1357
25. Gollins SW, Myint S, Levine E, et al., Phase I study of radiotherapy plus concurrent irinotecan and capecitabine as preoperative down-staging treatment for locally advanced inoperable rectal cancer. In: ASCO, Annual Meeting Proceedings, vol. 24; 2005. p. 3565.
26. Glynne-Jones R., Dunst J., and Sebag-Montefiore D. The integration of oral capecitabine into chemoradiation regimens for locally advanced rectal cancer: how successful have we been?. Ann Oncol 17 (2006) 361-371